Zentalis Pharmaceuticals, Inc.

Q2 2020 13F Holders

Symbol
ZNTL
CUSIP
98943L107
Type
Equity
Class
COM
Num filings
63
Total reported value, excl. options
$1.29 B
Manager Report Date Value ($000) Shares Option Type